Menu Search
Equities

Solarvest Bioenergy Inc

0ZJ:FRA

Solarvest Bioenergy Inc

Actions
  • Price (EUR)0.144
  • Today's Change0.004 / 2.86%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 16 2021 08:16 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.
Start Survey

Profile data is unavailable for this security.

About the company

Solarvest BioEnergy Inc. is a Canada-based algae technology company, which is engaged in the development of specially selected algal-based production systems to produce natural-based green commercial products, such as nutritional products, oils and biologic therapies, among others. The Company is focused on developing algae strains that are rich in Docosahexaenoic Acid/ Eicosapentaenoic Acid (DHA/EPA), which are a form of Omega 3 fatty acids used by the food enhancement and Nutraceutical markets. It is also focuses on developing algae strains that can be used to produce proteins with the first such target being a therapeutic that has use in human and animal orthopedic surgery and genetically modified algae strain that can be used to produce hydrogen. It is also focused on custom producing organic chemical-free Omega 3s and other nutritional oils. Its subsidiaries include Phycobiologics (Europe) Limited, Phyco Hydrogen Inc. and Solarvest (P.E.I.) Inc.

  • Revenue in CAD (TTM)11.20k
  • Net income in CAD-2.23m
  • Incorporated2005
  • Employees--
  • Location
    Solarvest Bioenergy Inc439 Helmcken StreetVANCOUVER V6B2E6CanadaCAN
  • Phone+1 (416) 420-0947
  • Fax+1 (604) 684-3323
  • Websitehttp://www.solarvest.ca/
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image